CHEMOMAB THERAPEUTICS LTD's ticker is CMMB and the CUSIP is 16385C104. A total of 16 filers reported holding CHEMOMAB THERAPEUTICS LTD in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,005,940 | -31.9% | 2,241,274 | 0.0% | 0.04% | -18.9% |
| Q2 2023 | $2,947,275 | -17.3% | 2,241,274 | 0.0% | 0.05% | -24.3% |
| Q1 2023 | $3,563,626 | -56.8% | 2,241,274 | -13.1% | 0.07% | -55.7% |
| Q4 2022 | $8,250,157 | +28.5% | 2,578,174 | 0.0% | 0.16% | +32.8% |
| Q3 2022 | $6,420,000 | -32.7% | 2,578,174 | 0.0% | 0.12% | -31.2% |
| Q2 2022 | $9,539,000 | -22.9% | 2,578,174 | 0.0% | 0.17% | -13.9% |
| Q1 2022 | $12,375,000 | -30.4% | 2,578,174 | 0.0% | 0.20% | -12.2% |
| Q4 2021 | $17,789,000 | -37.7% | 2,578,174 | 0.0% | 0.23% | -27.1% |
| Q3 2021 | $28,566,000 | -41.7% | 2,578,174 | 0.0% | 0.31% | -36.7% |
| Q2 2021 | $49,037,000 | -33.8% | 2,578,174 | 0.0% | 0.50% | -28.3% |
| Q1 2021 | $74,019,000 | – | 2,578,174 | – | 0.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 2,578,174 | $12,375,000 | 0.20% |
| Ikarian Capital, LLC | 268,104 | $1,292,000 | 0.17% |
| Cormorant Asset Management, LP | 288,168 | $1,383,000 | 0.11% |
| BOOTHBAY FUND MANAGEMENT, LLC | 41,298 | $198,000 | 0.01% |
| MEITAV INVESTMENT HOUSE LTD | 35,024 | $167,000 | 0.00% |
| Newbridge Financial Services Group, Inc. | 1,100 | $5,000 | 0.00% |
| ENVESTNET ASSET MANAGEMENT INC | 10,807 | $52,000 | 0.00% |
| JPMORGAN CHASE & CO | 753 | $4,000 | 0.00% |
| Renaissance Technologies | 27,960 | $134,000 | 0.00% |
| ARK Investment Management | 792 | $4,000 | 0.00% |